NCC received a ₹2,063 crore order from the Assam Government for the expansion of Gauhati Medical College & Hospital. The project includes construction and development work. The announcement is accompanied by updated market data and the latest NCC and share price information.
Source: NCC Limited Press Release (BSE Exchange Filings) | Published on Nov 25, 2025
Disclaimer: This content has been published for informational purposes only. Bajaj Broking is not affiliated with, nor does it endorse or assume any responsibility for, the source material. Readers are advised to consult the original publication for complete and accurate context.
As quoted in the press release from NCC and its news (NSE Exchange Filings), the company received a ₹2,063 crore work order from the Assam Government. The project involves the expansion of Gauhati Medical College & Hospital. The announcement records the project’s value, the scope of work and the awarding authority. It provides a clear outline of the construction activities linked to the project.
Also read: Transformers & Rectifiers Wins ₹389.97 Cr Order from GETCO
Total Amount: ₹2063 Crore
Authorised By: The Assam Government
What are they doing: Expanding the Gauhati Medical College & Hospital.
Scope of Work: See project scope outlined below
Also read: Jayant Infratech Gets ₹162 Crore Konkan Railway EPC Contract
NCC stated that the Assam Government has issued a work order valued at ₹2,063 crore. The order covers development and construction work for the expansion of Gauhati Medical College & Hospital. The filing records the financial size of the project and confirms the nature of the assigned work.
The update mentions that the project falls under NCC’s regular civil construction activities. It notes the defined scope without adding projections or assumptions. All information is based on the issued communication from the awarding authority. The filing presents only confirmed work details.
The project involves construction and civil development tasks required for the expansion of the medical facility. The scope includes building activities and related project-execution work. The update lists the responsibilities under the awarded contract in clear terms.
The filing also explains that the order aligns with NCC’s project portfolio in public-sector development. It provides factual details about the construction tasks without interpretive statements. The communication remains within standard disclosure norms.
Particulars | Details |
Awarding Authority | Assam Government |
Project Value | ₹2,063 crore |
Project Type | Expansion of Gauhati Medical College & Hospital |
Work Scope | Construction and development |
Project Category | Public infrastructure |
The announcement records the order in line with disclosure requirements. It reports the project’s value and the nature of assigned tasks. The communication does not include views on future performance or market impact. The details reflect the company’s obligation to share confirmed project information.
As per the displayed market data on 25 November 2025 at 15:30 IST, the NCC share price was ₹173.90. The previous close was ₹172.35, and the stock opened at ₹172.35. The intraday high reached ₹173.91, the low was ₹171.71 and the recorded close was ₹173.23. The VWAP for the session was ₹172.69.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading